Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Clinigen Group PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Jun 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Clinigen Group PLC (CLIN-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

01 Jul 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Clinigen Group PLC

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

12 Jun 2015 Wright Reports 54 $75.00

CLINIGEN GROUP - IDIS ACQUISITION DRIVES THE STRATEGY FORWARDS

Clinigen has acquired Idis for £225m. Idis operates in the same highly specialised and defensive niches of clinical trials su...

09 Jun 2015 Edison Investment Research 12 $10.00

Company Snapshot - Clinigen Group

A director at Clinigen Group sold 23,934 shares at 644p and the significance rating of the trade was 60/100. Is that informa...

04 Jun 2015 Directors Deals Ltd. 1 $12.00

Clinigen Group plc (CLIN) - Financial Analysis Review

Clinigen Group plc (CLIN) - Financial Analysis Review Summary Clinigen Group plc (Clinigen Group) is a specialty pharma...

03 Jun 2015 GlobalData 40 $125.00

Peel Hunt: Clinigen (Buy) - Bigger and better, and an even stronger Buy

Clinigen (Buy) Bigger and better, and an even stronger Buy Clinigen's £225m acquisition of Idis is strategically compelling...

06 May 2015 Peel Hunt 21 $230.00

Peel Hunt: Clinigen (Buy) - Acquisition of Idis creates a global leader

Peel Hunt: Clinigen (Buy) - Acquisition of Idis creates a global leader

24 Apr 2015 Peel Hunt 3 $23.00

Clinigen Group plc (CLIN) - Financial Analysis Review

Clinigen Group plc (CLIN) - Financial Analysis Review Summary Clinigen Group plc (Clinigen Group) is a specialty pharma...

10 Mar 2015 GlobalData 39 $125.00

CLINIGEN GROUP - CONTINUING PROGRESS ACROSS ALL THREE DIVISIONS

Clinigen has reported solid H115 results that confirm progress is being maintained as expected. All three divisions are now w...

03 Mar 2015 Edison Investment Research 3 $10.00